The downregulation of miR-96 upregulated SAMD9 which accelerates the action of cisplatin and suppresses lung cancer progression by regulating forkhead box O3 (FOXO3) (Wu et al., 2016). This evidence concerns the gene FOXO3 and lung carcinoma.